Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cusan

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Journal of Steroid Biochemistry|June 1, 1989
Influence of diet on plasma steroids and sex hormone-binding globulin levels in adult menA Bélanger, A Locong, C Noel, et al.
Urology|March 30, 1999
Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: three versus six months of endocrine therapyT H van der Kwast, B Têtu, B Candas, et al.
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|May 8, 1978
[Inhibitory effects of LHRH on LH receptors in the rat testis]C Auclair, L Ferland, L Cusan, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1992
Combination therapy with flutamide and castration (orchiectomy or LH-RH agonist) in untreated patients with advanced prostate cancerA Dupont, F Labrie, L Cusan, et al.
Steroids|June 10, 1998
DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during agingF Labrie, A Bélanger, V Luu-The, et al.
Progress in Clinical and Biological Research|January 1, 1988
Combination therapy with flutamide and [D-Trp6, des-Gly-NH2(10)]LHRH ethylamide in stage C and D prostate cancer: today's therapy of choice--rationale and 5-year clinical experienceF Labrie, A Dupont, L Cusan, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1991
Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal womenS Moorjani, A Dupont, F Labrie, et al.
British Journal of Urology|June 1, 1989
Anti-hormone treatment for prostate cancer relapsing after treatment with flutamide and castration. Addition of aminoglutethimide and low dose hydrocortisone to combination therapyF Labrie, A Dupont, A Bélanger, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 1, 1991
Steroid glucuronides: human circulatory levels and formation by LNCaP cellsA Bélanger, M Brochu, D Lacoste, et al.
The Prostate|April 1, 1996
Androgen receptor modulation in benign human prostatic tissue and prostatic adenocarcinoma during neoadjuvant endocrine combination therapyT H Van der Kwast, B Têtu, Y Fradet, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Journal of Steroid Biochemistry|June 1, 1989
Influence of diet on plasma steroids and sex hormone-binding globulin levels in adult menA Bélanger, A Locong, C Noel, et al.
Urology|March 30, 1999
Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: three versus six months of endocrine therapyT H van der Kwast, B Têtu, B Candas, et al.
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|May 8, 1978
[Inhibitory effects of LHRH on LH receptors in the rat testis]C Auclair, L Ferland, L Cusan, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1992
Combination therapy with flutamide and castration (orchiectomy or LH-RH agonist) in untreated patients with advanced prostate cancerA Dupont, F Labrie, L Cusan, et al.
Steroids|June 10, 1998
DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during agingF Labrie, A Bélanger, V Luu-The, et al.
Progress in Clinical and Biological Research|January 1, 1988
Combination therapy with flutamide and [D-Trp6, des-Gly-NH2(10)]LHRH ethylamide in stage C and D prostate cancer: today's therapy of choice--rationale and 5-year clinical experienceF Labrie, A Dupont, L Cusan, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1991
Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal womenS Moorjani, A Dupont, F Labrie, et al.
British Journal of Urology|June 1, 1989
Anti-hormone treatment for prostate cancer relapsing after treatment with flutamide and castration. Addition of aminoglutethimide and low dose hydrocortisone to combination therapyF Labrie, A Dupont, A Bélanger, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 1, 1991
Steroid glucuronides: human circulatory levels and formation by LNCaP cellsA Bélanger, M Brochu, D Lacoste, et al.
The Prostate|April 1, 1996
Androgen receptor modulation in benign human prostatic tissue and prostatic adenocarcinoma during neoadjuvant endocrine combination therapyT H Van der Kwast, B Têtu, Y Fradet, et al.
Pageof 10